Jakob O Gjørret

Title: Jakob O Gjørret: Innovator in Monoclonal Antibody Development

Introduction

Jakob O Gjørret is a notable inventor based in Holte, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on innovative solutions that have the potential to impact therapeutic applications.

Latest Patents

Jakob O Gjørret holds a patent for the PAX 5 monoclonal antibody. This invention relates to anti-human PAX 5 antibodies that are capable of binding to specific epitopes within the C-terminal regulatory domain of PAX 5. The patent details an antibody, antigen binding fragment, or recombinant protein that specifically binds to an epitope located within the C-terminal fragment of the human PAX 5 protein. The epitope comprises from 3 to 17 amino acid residues of the sequence GSPYYYSAAARGAAPPA (SEQ ID NO:2). The invention also encompasses immunogenic peptide sequences for the production of these antibodies, along with diagnostic and therapeutic applications that utilize the antibodies and their formulations.

Career Highlights

Jakob O Gjørret is associated with Dako Denmark A/S, a company known for its advancements in diagnostic solutions. His work at Dako has allowed him to contribute to the development of innovative products that enhance the capabilities of medical diagnostics.

Collaborations

Jakob has collaborated with notable colleagues such as Kirsten Damgaard Hoff and Henrik Winther. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biotechnology.

Conclusion

Jakob O Gjørret is a distinguished inventor whose work in monoclonal antibodies exemplifies the intersection of science and innovation. His contributions have the potential to advance therapeutic applications and improve diagnostic methods in healthcare.